Inventor · disambiguated record
Thomas Thum
Also filed as: THUM THOMAS
17 granted patents·17 pending applications·74 citations·filing 2001–2023
91Inventor score
Files withMEDIZINISCHE HOCHSCHULE HANNOVER12THUM THOMAS6UNIV WUERZBURG J MAXIMILIANS6FRAUNHOFER GES FORSCHUNG3CARDIOR PHARMACEUTICALS GMBH1
Top patents by PatentIndex Score
34 records- 0192US8592389B2MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposesTHUM THOMAS·Filed 2012·Granted Nov 26, 2013·21 cites·21 claims
- 0291US8236777B2MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposesTHUM THOMAS·Filed 2009·Granted Aug 7, 2012·17 cites·26 claims
- 0387US2024189339A1MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic PurposesUNIV WUERZBURG J MAXIMILIANS·Filed 2023·Application pending·0 cites
- 0485US8906870B2MicroRNA (miRNA) for the diagnosis and treatment of heart diseasesTHUM THOMAS·Filed 2007·Granted Dec 9, 2014·5 cites·6 claims
- 0585US8691783B2MicroRNA-24THUM THOMAS·Filed 2010·Granted Apr 8, 2014·16 cites·4 claims
- 0681US2023028937A1MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic PurposesUNIV WUERZBURG J MAXIMILIANS·Filed 2022·Application pending·0 cites
- 0779US6558929B2PCR reaction mixture for fluorescence-based gene expression and gene mutation analysesFRAUNHOFER GES FORSCHUNG·Filed 2001·Granted May 6, 2003·13 cites·22 claims
- 0874US11186838B2LNCRNA MEG3 for therapy and diagnosis of cardiac remodellingMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2017·Granted Nov 30, 2021·2 cites·7 claims
- 0972US2021113603A1MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic PurposesUNIV WUERZBURG J MAXIMILIANS·Filed 2020·Application pending·0 cites
- 1069US2020069720A1MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic PurposesUNIV WUERZBURG J MAXIMILIANS·Filed 2019·Application pending·0 cites
- 1168US10434117B2MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposesUNIV WUERZBURG J MAXIMILIANS·Filed 2018·Granted Oct 8, 2019·0 cites·10 claims
- 1267US2022348920A1Lncrnas for therapy and diagnosis of cardiac hypertrophyMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2022·Application pending·0 cites
- 1367US2022315924A1Lncrnas for therapy and diagnosis of cardiac hypertrophyMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2022·Application pending·0 cites
- 1465US10028974B2MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposesUNIV WUERZBURG J MAXIMILIANS·Filed 2017·Granted Jul 24, 2018·0 cites·11 claims
- 1562US11459561B2IncRNAS for therapy and diagnosis of angiogenesisMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2019·Granted Oct 4, 2022·0 cites·8 claims
- 1662US11371043B2LncRNAs for therapy and diagnosis of cardiac hypertrophyMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2018·Granted Jun 28, 2022·0 cites·8 claims
- 1758US9220722B2Microrna (miRNA) and downstream targets for diagnostic and therapeutic purposesJULIUS MAXIMILIANS UNI WURZBURG·Filed 2013·Granted Dec 29, 2015·0 cites·22 claims
- 1855US9663788B2MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposesJULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG·Filed 2015·Granted May 30, 2017·0 cites·23 claims
- 1953US10221417B2LncRNAs for therapy and diagnosis of angiogenesisMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2015·Granted Mar 5, 2019·0 cites·8 claims
- 2052US2016177391A1Analysis for takotsubo cardiomyopathy by means of differentially regulated microrna moleculesHANNOVER MED HOCHSCHULE·Filed 2014·Application pending·0 cites
- 2149US2023235403A1Long non-coding rna as therapeutic target in cardiac disorders and cardiac regenerationMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2021·Application pending·0 cites
- 2248US11208651B2Compound for treatment of heart failureMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2018·Granted Dec 28, 2021·0 cites·28 claims
- 2348US2017183652A1Lncrnas for therapy and diagnosis of cardiac hypertrophyMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2015·Application pending·0 cites
- 2448US2023074198A1Viral vector particle based on AA V2 for gene therapyMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2021·Application pending·0 cites
- 2547US2006258632A1Methods and agents for treating cardiovascular diseasesFRAUNHOFER GES FORSCHUNG·Filed 2006·Application pending·0 cites
- 2646US2012202201A1Device and method for analysis of kidney failureTHUM THOMAS·Filed 2012·Application pending·0 cites
- 2746US2015267254A1Microrna profiles in the diagnosis of multiple sclerosisST JOSEF UND ST ELISABETH HOSPITAL GMBH·Filed 2013·Application pending·0 cites
- 2845US2024299584A1Non-coding rna protecting against heart failureMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2020·Application pending·0 cites
- 2943US2004110733A1Methods and agents for treating cardiovascular diseasesFRAUNHOFER GES FORSCHUNG·Filed 2002·Application pending·0 cites
- 3040US2017240969A1A circulating non-coding rna as predictor of mortality in patients with acute kidney injuryMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2015·Application pending·0 cites
- 3139US9388411B2miRNA-212/132 family as a therapeutic targetTHUM THOMAS·Filed 2012·Granted Jul 12, 2016·0 cites·23 claims
- 3238US2022243204A1Treatment of heart failure in human subjectsCARDIOR PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 3333US11185539B2Natural compounds and fibrosisMEDIZINISCHE HOCHSCHULE HANNOVER MHH·Filed 2018·Granted Nov 30, 2021·0 cites·6 claims
- 3419US10584383B2Mitochondrial non-coding RNAs for predicting disease progression in heart failure and myocardial infarction patientsINST PASTEUR DE LILLE IPL·Filed 2015·Granted Mar 10, 2020·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Thum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →